Featured Article
Untangling the evolution of cancer
Here at the ICR, Professor Mel Greaves applies evolutionary thinking to illuminate how cancers work.
Plan for action to fight global cancer unveiled
04 Feb 2013
A 10-point plan to turn back the tide on cancer has been published to mark World Cancer Day. Developed by the World Oncology Forum, including the ICR's Professor Stan Kaye, the plan calls for more focus on research, and for governments around the world to invest in better healthcare systems to help reduce the number of people dying from the disease.
New Tumour Profiling Unit signals push for personalised cancer treatment
29 Jan 2013
A new Tumour Profiling Unit at the ICR will accelerate the development of personalised cancer treatments and their delivery to patients.
Launch of trial of 'master switch' drug to treat several cancer types
16 Jan 2013
Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The early-stage Phase I clinical trial of up to 40 patients will be carried out by the ICR, and The Royal Marsden Hospital.
'Virtual experiments' aid scientists to find missing cancer targets
31 Dec 2012
Scientists have identified 46 previously overlooked but potentially ‘druggable’ cancer targets, using a powerful new online approach that allows researchers to carry out ‘virtual experiments’ to quickly prioritise which are the best targets for drug discovery.
See 2013 Press Release Archive |
